Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease

Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease

BackgroundChronic obstructive pulmonary disease (COPD) is a prevalent condition that significantly impacts public health. Unfortunately, there are few effective treatment options available. Mendelian randomization (MR) has been utilized to repurpose existing drugs and identify new therapeutic target...

Full description

Bibliographic Details
Main Authors:	Zihui Wang, Shaoqiang Li, Guannan Cai, Yuan Gao, Huajing Yang, Yun Li, Juncheng Liang, Shiyu Zhang, Jieying Hu, Jinping Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	Mendelian randomization druggable genes drugs repurposing chronic obstructive pulmonary disease lung function
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2024.1386506/full

Similar Items

TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
by: Qing-Qing Duan, et al.
Published: (2024-03-01)

Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes
by: Zetao Liu, et al.
Published: (2024-05-01)

Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia
by: Kang‐Fu Yin, et al.
Published: (2024-08-01)

Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization
by: Chengcheng Zhang, et al.
Published: (2024-06-01)

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
by: Wenfu Song, et al.
Published: (2024-06-01)

Identification of therapeutic target genes for age-related hearing loss through systematic genome-wide mendelian randomization of druggable genes
by: Kun Zhang, et al.
Published: (2025-02-01)

Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analysesResearch in context
by: Naiqi Zhang, et al.
Published: (2023-12-01)

Proteome-wide Mendelian randomization provides novel insights into the pathogenesis and druggable targets of osteoporosis
by: Jingchuan Yan, et al.
Published: (2024-10-01)

Uncovering Druggable Targets in Aortic Dissection: An Association Study Integrating Mendelian Randomization, pQTL, and Protein–Protein Interaction Network
by: Daisong Jiang, et al.
Published: (2024-05-01)

Enhancer promoter interactome and Mendelian randomization identify network of druggable vascular genes in coronary artery disease
by: Arnaud Chignon, et al.
Published: (2022-03-01)

The druggable genome: Twenty years later
by: Chris J. Radoux, et al.
Published: (2022-09-01)

Unraveling genetic threads: Identifying novel therapeutic targets for allergic rhinitis through Mendelian randomization
by: Xuerong Huang, MD, et al.
Published: (2024-07-01)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
by: Syed S. Hassan, et al.
Published: (2018-02-01)

Plectasin: from evolution to truncation, expression, and better druggability
by: Xuan Li, et al.
Published: (2023-12-01)

Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis
by: Jiao Li, et al.
Published: (2024-03-01)

Causal association between sarcopenia and chronic obstructive pulmonary disease: A two-sample Mendelian randomization
by: Jun Ma, et al.
Published: (2025-02-01)

Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins
by: Sina Ghadermarzi, et al.
Published: (2019-11-01)

Covalency-enabled Drug Discovery is Redefining Druggability
by: Jeffrey M. McKenna, et al.
Published: (2023-08-01)

Mendelian randomization of circulating proteome identifies actionable targets in heart failure
by: Louis-Hippolyte Minvielle Moncla, et al.
Published: (2022-08-01)

Bidirectional Causal Association Between Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: A Mendelian Randomization Study
by: Yu G, et al.
Published: (2024-09-01)

Association of Chronic Obstructive Pulmonary Disease with Risk of Psychiatric Disorders: A Two-Sample Mendelian Randomization Study
by: Zhang Q, et al.
Published: (2024-02-01)

Molecular Dynamics Simulations of Influenza A Virus NS1 Reveal a Remarkably Stable RNA-Binding Domain Harboring Promising Druggable Pockets
by: Hiba Abi Hussein, et al.
Published: (2020-05-01)

Targeting KRAS mutant cancers: from druggable therapy to drug resistance
by: Chunxiao Zhu, et al.
Published: (2022-08-01)

Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability
by: Marina Pierrevelcin, et al.
Published: (2020-08-01)

Repurposing antihypertensive drugs for pain disorders: a drug-target mendelian randomization study
by: Kai Du, et al.
Published: (2024-08-01)

Causal Role of Immune Cells in Chronic Obstructive Pulmonary Disease: A Two-Sample Mendelian Randomization Study
by: Xinru Xiao, et al.
Published: (2024-12-01)

Causal Involvement of Immune Cells in Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study
by: Guan T, et al.
Published: (2024-07-01)

A Bidirectional Mendelian Randomization Study Investigating the Causal Relationship Between Ankylosing Spondylitis and Chronic Obstructive Pulmonary Disease
by: Pan D, et al.
Published: (2025-02-01)

Sex Hormones and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study and Mendelian Randomization Analysis
by: Du D, et al.
Published: (2024-07-01)

PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
by: Nuwayo Ishimwe Sincere, et al.
Published: (2023-05-01)

Association of Physical Activity with Asthma and Chronic Obstructive Pulmonary Disease and Mediation of Frailty: Mendelian Randomization Analyses
by: Chen N, et al.
Published: (2024-10-01)

Periodontal disease increases the severity of chronic obstructive pulmonary disease: a Mendelian randomization study
by: Bao-Ling Zhao, et al.
Published: (2024-05-01)

A Mendelian randomization study for drug repurposing reveals bezafibrate and fenofibric acid as potential osteoporosis treatments
by: Xiao-Hua Li, et al.
Published: (2023-07-01)

DPI_CDF: druggable protein identifier using cascade deep forest
by: Muhammad Arif, et al.
Published: (2024-04-01)

Editorial: Antimicrobial peptides and their druggability, bio-safety, stability, and resistance
by: Xuanxuan Ma, et al.
Published: (2024-05-01)

In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
by: Maurice Michel, et al.
Published: (2020-05-01)

Evolutionary druggability for low-dimensional fitness landscapes toward new metrics for antimicrobial applications
by: Rafael F Guerrero, et al.
Published: (2024-06-01)

PINNED: identifying characteristics of druggable human proteins using an interpretable neural network
by: Michael Cunningham, et al.
Published: (2023-07-01)

The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa
by: Abdul Rahman Jazieh, et al.
Published: (2019-02-01)

Association between chronic obstructive pulmonary disease and osteoporosis: Mendelian randomization combined with bibliometric analysis
by: Fangjun Yang, et al.
Published: (2025-02-01)